Literature DB >> 27841792

Thermal Ablation of the Pancreas With Intraoperative High-Intensity Focused Ultrasound: Safety and Efficacy in a Porcine Model.

Aurélien Dupré1, David Melodelima, Hannah Pflieger, Yao Chen, Jérémy Vincenot, Anthony Kocot, Stéphan Langonnet, Michel Rivoire.   

Abstract

OBJECTIVE: New focal destruction technologies such as high-intensity focused ultrasound (HIFU) may improve the prognosis of pancreatic ductal adenocarcinoma. Our objectives were to demonstrate the safety and efficacy of intraoperative pancreatic HIFU ablation in a porcine model.
METHODS: In a porcine model (N = 12), a single HIFU ablation was performed in either the body or tail of the pancreas, distant to superior mesenteric vessels. All animals were sacrificed on the eighth day. The primary objective was to obtain an HIFU ablation measuring at least 1 cm without premature death.
RESULTS: In total, 12 HIFU ablations were carried out. These ablations were performed within 160 seconds and on average measured 20 (15-27) × 16 (8-26) mm. The primary objective was fulfilled in all but 1 pig. There were no premature deaths or severe complications. High-intensity focused ultrasound treatment was associated with a transitory increase in amylase and lipase levels, and pseudocysts were observed in half of the pigs without being clinically apparent. All ablations were well delimited at both gross and histological examinations.
CONCLUSIONS: Intraoperative thermal destruction of porcine pancreas with HIFU is feasible. Reproducibility and safety have to be confirmed when applied close to mesenteric vessels and in long-term preclinical studies.

Entities:  

Mesh:

Year:  2017        PMID: 27841792     DOI: 10.1097/MPA.0000000000000720

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

Review 1.  High-intensity focused ultrasound therapy for pancreatic cancer.

Authors:  Atsushi Sofuni; Yasutsugu Asai; Shuntaro Mukai; Kenjiro Yamamoto; Takao Itoi
Journal:  J Med Ultrason (2001)       Date:  2022-05-12       Impact factor: 1.314

Review 2.  Pancreatic Ductal Adenocarcinoma: Current and Emerging Therapeutic Uses of Focused Ultrasound.

Authors:  Maxime Lafond; Thomas Lambin; Robert Andrew Drainville; Aurélien Dupré; Mathieu Pioche; David Melodelima; Cyril Lafon
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

3.  A causal study of the phenomenon of ultrasound neurostimulation applied to an in vivo invertebrate nervous model.

Authors:  Jérémy Vion-Bailly; W Apoutou N'Djin; Ivan Mauricio Suarez Castellanos; Jean-Louis Mestas; Alexandre Carpentier; Jean-Yves Chapelon
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

Review 4.  Thermosensitive Nanosystems Associated with Hyperthermia for Cancer Treatment.

Authors:  Isabela Pereira Gomes; Jaqueline Aparecida Duarte; Ana Luiza Chaves Maia; Domenico Rubello; Danyelle M Townsend; André Luís Branco de Barros; Elaine Amaral Leite
Journal:  Pharmaceuticals (Basel)       Date:  2019-11-25

5.  Novel Therapeutic Method for Unresectable Pancreatic Cancer-The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy.

Authors:  Atsushi Sofuni; Yasutsugu Asai; Takayoshi Tsuchiya; Kentaro Ishii; Reina Tanaka; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Kazumasa Nagai; Kenjiro Yamamoto; Yukitoshi Matsunami; Takashi Kurosawa; Hiroyuki Kojima; Toshihiro Homma; Hirohito Minami; Ryosuke Nakatsubo; Noriyuki Hirakawa; Hideaki Miyazawa; Yuichi Nagakawa; Akihiko Tsuchida; Takao Itoi
Journal:  Curr Oncol       Date:  2021-11-20       Impact factor: 3.677

6.  Intraoperative HIFU Ablation of the Pancreas Using a Toroidal Transducer in a Porcine Model. The First Step towards a Clinical Treatment of Locally Advanced Pancreatic Cancer.

Authors:  Celia Cilleros; Aurélien Dupré; Yao Chen; Jeremy Vincenot; Michel Rivoire; David Melodelima
Journal:  Cancers (Basel)       Date:  2021-12-20       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.